Skip to main content
. Author manuscript; available in PMC: 2021 Nov 29.
Published in final edited form as: Pediatr Diabetes. 2020 Aug 25;21(7):1116–1125. doi: 10.1111/pedi.13093

Table 3.

Comparison amongst the three LPA classes

Poor Control (1) Durable Control (2) Transient Response (3) Pairwise Two-Sided Multiple Comparison
n(%) N(%) or Mean(SD) or Median(IQR) N(%) or Mean(SD) or Median(IQR) N(%) or Mean(SD) or Median(IQR) P-value 1 vs 2 2 vs 3 1 vs 3
HbA1c at diagnosis 192 11.76 (2.20) 9.40 (2.77) 12.30 (2.46) <0.0001 0.0001 <0.0001 0.4576
C-peptide 143 3.63 (3.11) 3.58 (3.45) 1.82 (1.46) 0.0020 0.9589 0.0024 0.0074
Attended follow-up visit at 1 year§ 183 0.2396
Y 159 (86.9) 18 (85.7) 113 (90.4) 24 (80.0)
N 24 (13.1) 3 (14.3) 12 (9.6) 6 (20.0
Medication at diagnosis§ 172 21 120 31 <0.0001 <0.0001 0.0020 0.4792
Metformin only 1(4.8) 56(46.7) 4(12.9)
Insulin only 12(57.1) 49(40.8) 19(61.3)
Metformin+Insulin 5(23.8) 13(10.8) 7(22.6)
Other 3(1.7) 2(1.7) 1(3.2)

Variable of normal distribution is presented as mean and SD. P-value calculated using one-way ANOVA. The least-square means in generalized linear model was performed for pairwise comparisons.

Variable demonstrating non-normal distribution is presented as median and interquartile range (IQR). P-value calculated using the Kruskal-Wallis test. DSCF procedure was used for pairwise comparisons.

§

Categorical variables were presented as counts and percentages. P-value for comparison across the three groups was calculated by the Fisher exact test. DSCF procedure was used for pairwise comparisons.